Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Quizartinib |
Appearance | White or off-white crystalline powder |
Latin Name | AC220 |
CAS NO | 950769-58-1 |
MF | C29H32N6O4S |
MW | 560.66718 |
Assay | 99% |
Shelf life | 2 years |
Brand | Sonwu |
Quizartinib (AC220) is a second-generation FLT3 inhibitor, acts on Flt3 (ITD/WT), with IC50 of 1.1 nM/4.2 nM in MV4-11 and RS4;11 cells, respectively, acts on Flt3 than on KIT, PDGFRA , PDGFRB, RET, and CSF-1R with 10-fold selectivity.
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance